Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Somatic mutations of the protein kinase gene family in human lung cancer.

Davies H, Hunter C, Smith R, Stephens P, Greenman C, Bignell G, Teague J, Butler A, Edkins S, Stevens C, Parker A, O'Meara S, Avis T, Barthorpe S, Brackenbury L, Buck G, Clements J, Cole J, Dicks E, Edwards K, Forbes S, Gorton M, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jones D, Kosmidou V, Laman R, Lugg R, Menzies A, Perry J, Petty R, Raine K, Shepherd R, Small A, Solomon H, Stephens Y, Tofts C, Varian J, Webb A, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Green A, Knowles M, Leung SY, Looijenga LH, Malkowicz B, Pierotti MA, Teh BT, Yuen ST, Lakhani SR, Easton DF, Weber BL, Goldstraw P, Nicholson AG, Wooster R, Stratton MR, Futreal PA.

Cancer Res. 2005 Sep 1;65(17):7591-5.

2.

Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.

Strazisar M, Mlakar V, Rott T, Glavac D.

Cancer Invest. 2009 May;27(4):407-16. doi: 10.1080/07357900802427919.

PMID:
19229701
3.

Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer.

Gemma A, Seike M, Seike Y, Uematsu K, Hibino S, Kurimoto F, Yoshimura A, Shibuya M, Harris CC, Kudoh S.

Genes Chromosomes Cancer. 2000 Nov;29(3):213-8.

PMID:
10992296
4.
5.

ERBB2 kinase domain mutation in the lung squamous cell carcinoma.

Lee JW, Soung YH, Kim SY, Nam SW, Park WS, Wang YP, Jo KH, Moon SW, Song SY, Lee JY, Yoo NJ, Lee SH.

Cancer Lett. 2006 Jun 8;237(1):89-94. Epub 2005 Jul 18.

PMID:
16029927
6.

Somatic mutations in human cancer: insights from resequencing the protein kinase gene family.

Futreal PA, Wooster R, Stratton MR.

Cold Spring Harb Symp Quant Biol. 2005;70:43-9.

PMID:
16869737
7.

Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.

Okano T, Gemma A, Hosoya Y, Hosomi Y, Nara M, Kokubo Y, Yoshimura A, Shibuya M, Nagashima M, Harris CC, Kudoh S.

Oncol Rep. 2006 Mar;15(3):545-9.

PMID:
16465410
8.
9.

Molecular context of the EGFR mutations: evidence for the activation of mTOR/S6K signaling.

Conde E, Angulo B, Tang M, Morente M, Torres-Lanzas J, Lopez-Encuentra A, Lopez-Rios F, Sanchez-Cespedes M.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):710-7.

10.

Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lung.

Marchetti A, Felicioni L, Pelosi G, Del Grammastro M, Fumagalli C, Sciarrotta M, Malatesta S, Chella A, Barassi F, Mucilli F, Camplese P, D'Antuono T, Sacco R, Buttitta F.

Hum Mutat. 2008 May;29(5):609-16. doi: 10.1002/humu.20707.

PMID:
18293376
11.

Mutational analysis of proapoptotic caspase-9 gene in common human carcinomas.

Soung YH, Lee JW, Kim SY, Park WS, Nam SW, Lee JY, Yoo NJ, Lee SH.

APMIS. 2006 Apr;114(4):292-7.

PMID:
16689829
12.

A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer.

Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C, Bignell G, Teague J, Smith R, Stevens C, O'Meara S, Parker A, Tarpey P, Avis T, Barthorpe A, Brackenbury L, Buck G, Butler A, Clements J, Cole J, Dicks E, Edwards K, Forbes S, Gorton M, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jones D, Kosmidou V, Laman R, Lugg R, Menzies A, Perry J, Petty R, Raine K, Shepherd R, Small A, Solomon H, Stephens Y, Tofts C, Varian J, Webb A, West S, Widaa S, Yates A, Brasseur F, Cooper CS, Flanagan AM, Green A, Knowles M, Leung SY, Looijenga LH, Malkowicz B, Pierotti MA, Teh B, Yuen ST, Nicholson AG, Lakhani S, Easton DF, Weber BL, Stratton MR, Futreal PA, Wooster R.

Nat Genet. 2005 Jun;37(6):590-2. Epub 2005 May 22.

PMID:
15908952
13.

LKB1 gene mutations in Japanese lung cancer patients.

Onozato R, Kosaka T, Achiwa H, Kuwano H, Takahashi T, Yatabe Y, Mitsudomi T.

Cancer Sci. 2007 Nov;98(11):1747-51. Epub 2007 Aug 16.

14.
15.

KLF6: mutational analysis and effect on cancer cell proliferation.

Yin D, Komatsu N, Miller CW, Chumakov AM, Marschesky A, McKenna R, Black KL, Koeffler HP.

Int J Oncol. 2007 Jan;30(1):65-72.

PMID:
17143513
16.

O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.

Chae MH, Jang JS, Kang HG, Park JH, Park JM, Lee WK, Kam S, Lee EB, Son JW, Park JY.

Mol Carcinog. 2006 Apr;45(4):239-49.

PMID:
16385589
17.

Absence of epidermal growth factor receptor mutations in cervical cancer.

Arias-Pulido H, Joste N, Chavez A, Muller CY, Dai D, Smith HO, Verschraegen CF.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):749-54. Epub 2007 Oct 19.

PMID:
17949425
18.

Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines.

Yamaguchi K, Okami K, Hibi K, Wehage SL, Jen J, Sidransky D.

Cancer Lett. 1999 May 24;139(2):183-7.

PMID:
10395177
19.

Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.

Tam IY, Chung LP, Suen WS, Wang E, Wong MC, Ho KK, Lam WK, Chiu SW, Girard L, Minna JD, Gazdar AF, Wong MP.

Clin Cancer Res. 2006 Mar 1;12(5):1647-53.

20.

PIK3CA mutation status in Japanese lung cancer patients.

Kawano O, Sasaki H, Endo K, Suzuki E, Haneda H, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Lung Cancer. 2006 Nov;54(2):209-15. Epub 2006 Aug 22.

PMID:
16930767

Supplemental Content

Support Center